✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Unichem Laboratories Ltd.

UNICHEMLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹2,724 Cr.
P/E
9.24

Unichem Laboratories Ltd.

  • Unichem Lab
  • Panacea Biotec
  • Gufic Biosciences
  • TJI Pharma - Small Cap

FAQs on Unichem Laboratories Ltd. Shareprice

Unichem Lab has given lower returns compared to its competitors.
Unichem Lab has grown at ~6.5% over the last 10yrs while peers have grown at a median rate of 14.94%

Unichem Lab is not expensive.
Latest PE of Unichem Lab is 9.24, while 3 year average PE is 35.45.
Also latest EV/EBITDA of Unichem Lab is 13.83 while 3yr average is 81.34.

View FAQ's On Business

Growth Table

  • Unichem Laboratories Ltd.
  • Panacea Biotec
  • Gufic Biosciences

Balance Sheet

  • Unichem Laboratories Ltd.
  • Panacea Biotec
  • Gufic Biosciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Unichem Laboratories Ltd.
  • Panacea Biotec
  • Gufic Biosciences

Cash Flow

  • Unichem Laboratories Ltd.
  • Panacea Biotec
  • Gufic Biosciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Unichem Laboratories Ltd.
  • Panacea Biotec
  • Gufic Biosciences

Quarterly Results

  • Unichem Laboratories Ltd.
  • Panacea Biotec
  • Gufic Biosciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Unichem Laboratories Ltd. Financials

Balance sheet of Unichem Lab is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Unichem Lab is increasing.
Latest net debt of Unichem Lab is ₹280 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹195 Crs.

Yes, profit is increasing.
The profit of Unichem Lab is ₹295 Crs for TTM, ₹138 Crs for Mar 2025 and -₹93.76 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Unichem Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech